Cargando…

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry

Detalles Bibliográficos
Autores principales:	Perrone, SV, Klein, F, Cadeiras, M, Peradejordi, M, Daviccino, M, Suarez, JC, Garello, E, Macchia, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301017/ http://dx.doi.org/10.1186/cc2215

Ejemplares similares

Hemodynamic effects of levosimendan after surgery in LPS pretreated rabbits
por: Faivre, V, et al.
Publicado: (2003)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

HTLV-I proviral load in Argentinean subjects with indeterminate western blot patterns
por: Mangano, Andrea, et al.
Publicado: (2011)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results.
por: Ávalos, R, et al.
Publicado: (2015)

Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
por: Suominen, Pertti K
Publicado: (2011)

The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure
por: Korkmaz, Hasan, et al.
Publicado: (2019)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003)

The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery bypass grafting
por: Lilleberg, J, et al.
Publicado: (2002)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Genomic continuity of Argentinean Mennonites
por: Pardo-Seco, Jacobo, et al.
Publicado: (2016)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Qu, Chao, et al.
Publicado: (2022)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Repetitive Acute Hemodynamic Load: Progression From Systolic Decompensation to Cellular/Extracellular Compensation to Diastolic Decompensation
por: Zile, Michael R., et al.
Publicado: (2019)

Blood pressure level increase with altitude in three argentinean indigenous communities
por: Hirschler, Valeria, et al.
Publicado: (2019)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
por: Carnero Contentti, Edgar, et al.
Publicado: (2023)

Predictors of Acute Hemodynamic Decompensation in Early Sepsis: An Observational Study
por: Lee, Young Im, et al.
Publicado: (2016)

Electrocardiographic and other Noninvasive Hemodynamic Markers in Decompensated CHF Patients
por: Piccirillo, Gianfranco, et al.
Publicado: (2023)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Clinical and Genetic Spectrum of Stargardt Disease in Argentinean Patients
por: Mena, Marcela D., et al.
Publicado: (2021)

Genetic structure of Argentinean hexaploid wheat germplasm
por: Vanzetti, Leonardo S., et al.
Publicado: (2013)

Hemodynamics in induced whole body hyperthermia
por: Kerner, T, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_qvqqt6p7p8584k15eooqonaj24